Medical Devices: Page 153


  • Telemedicine CEO pleads guilty in $424M Medicare kickback scheme

    The executive admitted to seeking and getting bribes from patient recruiters, pharmacies and brace suppliers in return for arranging for doctors to order medically unnecessary orthotic braces.

    By Dana Elfin • Sept. 9, 2019
  • Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Axonics wins PMA for sacral neuromod system, challenging Medtronic

    The FDA approval allows the medtech to market its implantable, rechargeable device for treatment of fecal incontinence as it seeks further indications for overactive bladder and urinary retention.

    By Maria Rachal • Sept. 9, 2019
  • Boston Scientific's Farapulse pulsed field ablation device. Explore the Trendlineâž”
    Image attribution tooltip
    Permission granted by Boston Scientific
    Image attribution tooltip
    Trendline

    New medical devices are reshaping the medtech industry

    From pulsed field ablation devices to glucose sensors and surgical robotics, new medical technologies are transforming patient care and how people manage their health.

    By MedTech Dive staff
  • Image attribution tooltip
    Maria Rachal
    Image attribution tooltip

    NESTcc 1.0 aims to launch, be able to take unsolicited projects by end of year

    The National Evaluation System for health Technology Coordinating Center Task Force is also currently developing an active surveillance roadmap it aims to issue for public comment this fall.

    By David Lim • Sept. 6, 2019
  • FDA finalizes guidance on HDEs after AdvaMed scrutiny

    Industry advocates had criticized FDA's tight parameters on which humanitarian use devices are eligible to turn a profit, but the final guidance largely mirrors the draft.

    By Sept. 6, 2019
  • Racing Edwards, Abbott starts pivotal trial of tricuspid device

    The product, a sibling of MitraClip, could become the first transcatheter tricuspid device of its kind on the U.S. market.

    By Sept. 6, 2019
  • The FDA logo on a glass pane at the agency's campus in Silver Spring, Maryland.
    Image attribution tooltip
    Jacob Bell/MedTech Dive
    Image attribution tooltip

    FDA floats idea for assessing the risk-benefit profile of weight-loss devices

    Concerned that some patients lack access to effective weight-loss devices, the agency is seeking feedback to inform guidance that it says will help device developers offer a wider variety of tools.

    By Sept. 6, 2019
  • Image attribution tooltip
    Livongo
    Image attribution tooltip

    Livongo posts 'good enough' first earnings since IPO, but stock tanks

    The digital health company beat analysts' revenue targets, but a greater-than-expected loss on earnings per share contributed to a double-digit hit to its stock price in morning trading.

    By Maria Rachal • Sept. 5, 2019
  • Image attribution tooltip
    Dollar Photo Club
    Image attribution tooltip

    With partner iRhythm, Verily ramps up AFib efforts

    iRhythm committed almost $18 million to Verily to boost development of technology that helps deliver earlier warnings to individuals with asymptomatic or silent atrial fibrillation.

    By Maria Rachal • Sept. 5, 2019
  • Robotic tech used for cardiac intervention from 20 miles away

    Patients were treated remotely using telerobotic technology from Corindus, which was recently acquired by Siemens Healthineers.

    By Sept. 5, 2019
  • More Blue Cross plans now covering Senseonics' implantable glucose monitor

    The medtech recently snagged a new positive coverage decision from Health Care Services Corporation, the nation's fourth largest insurer, which operates Blue Cross Blue Shield plans covering 16 million members across five states.

    By Updated Oct. 15, 2019
  • Tool to bust coronary plaque with sonic waves wins FDA breakthrough nod

    Shockwave Medical, which went public in March, is enrolling patients in a pivotal trial to study the device in treating cardiovascular disease. Abiomed is among its backers.

    By Sept. 4, 2019
  • Stryker spends up to $500M to boost spine unit with imaging, robotics tech

    The medtech said Monday it completed its buy of Mobius Imaging, which makes a mobile CT scanner, and Cardan Robotics, which develops radiology procedure technologies. 

    By Maria Rachal • Updated Oct. 21, 2019
  • Biotronik's Orsiro stent beats Abbott's Xience in head-to-head trial

    The trial linked the "ultrathin" Orsiro to a lower rate of target lesion revascularization than Abbott's incumbent device.

    By Sept. 4, 2019
  • FDA sets November ethylene oxide sterilization, duodenoscope safety advisory panel

    The dual-topic expert panel will be tasked with developing recommendations for FDA on two of the largest challenges currently facing the Center for Devices and Radiological Health.

    By David Lim • Sept. 3, 2019
  • Weight-loss surgery for Type 2 diabetes could cut major heart risks, study suggests

    Published in JAMA and funded by Medtronic, results from the retrospective study have yet to be confirmed by randomized clinical trials.

    By Maria Rachal • Sept. 3, 2019
  • Regulators put out call for experts to join device advisory committees

    FDA is seeking people to sit on 18 panels that review medical device data and manufacturing regulations.

    By Sept. 2, 2019
  • FDA urges providers, manufacturers to transition to duodenoscopes with disposable parts

    Boston Scientific told investors last year single-use duodenoscopes represent a market opportunity of more than $1 billion dollars.

    By David Lim • Aug. 30, 2019
  • The FDA logo on a glass pane at the agency's campus in Silver Spring, Maryland.
    Image attribution tooltip
    Jacob Bell/MedTech Dive
    Image attribution tooltip

    Summer slowdown drags on for De Novos

    The FDA has not announced a De Novo clearance in 12 weeks. Two-thirds of the way through 2019, pacing suggests the overall number of novel device approvals won't match 2018's high.

    By Maria Rachal • Aug. 30, 2019
  • Image attribution tooltip
    Getty
    Image attribution tooltip

    McKesson, Philips devices flagged by DHS for cyber vulnerabilities

    Certain cardiovascular IT systems and ultrasound devices could be exploited by hackers, the Department of Homeland Security wrote in separate notices.

    By Aug. 30, 2019
  • Image attribution tooltip
    Jacob Bell
    Image attribution tooltip

    AdvaMed wins some, loses some in FDA guidance on managing uncertainty

    While the agency tweaked parts of the document in line with feedback from AdvaMed and other groups, it maintained its plan to hold advisory committee meetings on certain postmarket data and kept other contested proposals.

    By Aug. 30, 2019
  • Image attribution tooltip
    Kendall Davis
    Image attribution tooltip

    Medline, Vantage ethylene oxide emissions caused cancer, lawsuits claim

    Commercial sterilizer Sterigenics, which was forced to shut down a Willowbrook medical device sterilizing plant in February, is defending itself against at least 32 lawsuits in the same state court over similar claims.

    By David Lim • Aug. 29, 2019
  • Surmodics passes milestone in trial of Abbott-licensed paclitaxel-coated balloon

    Surmodics completed enrollment sooner than some analysts expected on a trial comparing its paclitaxel-coated balloon to Medtronic's IN.PACT Admiral.

    By Aug. 29, 2019
  • Elekta buys ProKnow to boost digital radiotherapy strategy

    The Swedish company says ProKnow's capabilities are of particular value to its large customers, potentially helping give it an edge over rivals such as Varian Medical Systems.

    By Aug. 29, 2019
  • Life Spine talks up global expansion weeks after DOJ hit

    The micro invasive spine tech maker says its products are now sold in 30 countries, including recent additions in South America.

    By Aug. 29, 2019
  • Medtronic's Ishrak set to retire after nearly decade as CEO

    The leadership shuffle paves the way for Restorative Therapies Group head Geoff Martha, who led Medtronic's nearly $43 billion takeover of Covidien in 2014, to take the helm in time for the medtech giant's next fiscal year.

    By Maria Rachal • Aug. 28, 2019